Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Atenolol reduces plasma melatonin concentration in man.

Literature DB >> 6860537

Atenolol reduces plasma melatonin concentration in man.

P J Cowen, S Fraser, R Sammons, A R Green.

Abstract

Entities: Chemical Species

Mesh：

Substances：

Year: 1983 PMID： 6860537 PMCID： PMC1427710 DOI： 10.1111/j.1365-2125.1983.tb02099.x

Source DB: PubMed Journal: Br J Clin Pharmacol ISSN： 0306-5251 Impact factor: 4.335

× No keyword cloud information.

11 in total

1. Pineal beta adrenergic receptor: correlation of binding of 3H-l-alprenolol with stimulation of adenylate cyclase.

Authors: M Zatz; J W Kebabian; J A Romero; R J Lefkowitz; J Axelrod
Journal: J Pharmacol Exp Ther Date: 1976-03 Impact factor: 4.030

2. Manic-depressive patients may be supersensitive to light.

Authors: A J Lewy; T A Wehr; F K Goodwin; D A Newsome; N E Rosenthal
Journal: Lancet Date: 1981-02-14 Impact factor: 79.321

3. Direct radioimmunoassay for melatonin in plasma.

Authors: S Fraser; P Cowen; M Franklin; C Franey; J Arendt
Journal: Clin Chem Date: 1983-02 Impact factor: 8.327

Review 4. The pineal gland: a neurochemical transducer.

Authors: J Axelrod
Journal: Science Date: 1974-06-28 Impact factor: 47.728

5. beta-Adrenoreceptor-blocking agents and the blood-brain barrier.

Authors: J M Cruickshank; G Neil-Dwyer; M M Cameron; J McAinsh
Journal: Clin Sci (Lond) Date: 1980-12 Impact factor: 6.124

6. Melatonin assays in body fluids.

Authors: J Arendt
Journal: J Neural Transm Suppl Date: 1978

7. Nocturnal elevation of plasma melatonin and urinary 5-hydroxyindoleacetic acid in young men: attempts at modification by brief changes in environmental lighting and sleep and by autonomic drugs.

Authors: G M Vaughan; R W Pelham; S F Pang; L L Loughlin; K M Wilson; K L Sandock; M K Vaughan; S H Koslow; R J Reiter
Journal: J Clin Endocrinol Metab Date: 1976-04 Impact factor: 5.958

8. Light suppresses melatonin secretion in humans.

Authors: A J Lewy; T A Wehr; F K Goodwin; D A Newsome; S P Markey
Journal: Science Date: 1980-12-12 Impact factor: 47.728

Review 9. Melatonin: reproductive effects.

Authors: R J Reiter; M D Rollag; E S Panke; A F Banks
Journal: J Neural Transm Suppl Date: 1978

10. Differential effect of benserazide (Ro4-4602) on the concentration of indoleamines in rat pineal and hypothalamus.

Authors: J Arendt; A K Ho; C Laud; A Marston; V Nohria; J A Smith; A M Symons
Journal: Br J Pharmacol Date: 1981-02 Impact factor: 8.739

12 in total

Review 1. Atenolol. A reappraisal of its pharmacological properties and therapeutic use in cardiovascular disorders.

Authors: A N Wadworth; D Murdoch; R N Brogden
Journal: Drugs Date: 1991-09 Impact factor: 9.546

2. An alpha 2 adrenoceptor antagonist, Org 3770, enhances nocturnal melatonin secretion in man.

Authors: E Palazidou; A Papadopoulos; A Sitsen; S Stahl; S Checkley
Journal: Psychopharmacology (Berl) Date: 1989 Impact factor: 4.530

3. The influence of acute and subchronic administration of various antidepressants on early morning melatonin plasma levels in healthy subjects: increases following fluvoxamine.

Authors: K Demisch; L Demisch; T Nickelsen; R Rieth
Journal: J Neural Transm Date: 1987 Impact factor: 3.575

4. Marked enhancement by clorgyline of nocturnal and daytime melatonin release in rhesus monkeys.

Authors: D L Murphy; N A Garrick; J L Hill; L Tamarkin
Journal: Psychopharmacology (Berl) Date: 1987 Impact factor: 4.530

5. Melatonin: an adjunctive treatment for cardiometabolic disease?

Authors: Helen J Burgess
Journal: Sleep Date: 2012-10-01 Impact factor: 5.849

6. Comparison of the effects of acute fluvoxamine and desipramine administration on melatonin and cortisol production in humans.

Authors: D J Skene; C J Bojkowski; J Arendt
Journal: Br J Clin Pharmacol Date: 1994-02 Impact factor: 4.335